Trial Profile
Evaluating the effect of immunisation with group B meningococcal vaccines on meningococcal carriage
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Apr 2024
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine group B (Primary)
- Indications Meningococcal group B infections
- Focus Therapeutic Use
- Acronyms Be on the TEAM; TEAM
- 13 Mar 2024 Status changed from active, no longer recruiting to completed.
- 08 Jan 2024 Planned End Date changed from 31 Dec 2023 to 31 Mar 2024.
- 08 Jan 2024 Status changed from completed to active, no longer recruiting.